Thain Lin Koh currently works at Amplogix Technology Sdn. Bhd., as Executive Director, Cabnet Holdings Bhd., as Executive Director from 2025, Advancenet Technology Sdn. Bhd., as Senior Product ...

Mr. King Tai Tan is an Independent Non-Executive Chairman at Oversea Enterprise Bhd., a Non-Executive Chairman at Focus Dynamics Group Bhd., a Chairman at ADF Capital Bhd., a Non-Independent Non ...

The CEO of Novo Holdings has warned that his $160 billion fund will slow down investment activity until the dust settles after the Trump administration’s tariff blitz. Trump’s attack on global ...

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the US to start to recover once a ban on compound copycats is enforced this month, its CEO said today after the company cut its 2025 ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight loss drugs Ozempic and Wegovy, have been absolutely plummeting. The company's stock price slid over ...

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would ...

In the sleepy suburb of Bagsværd, a 25-minute train ride from Denmark’s capital of Copenhagen, weight-loss drugmaker Novo Nordisk is everywhere. Street after street is filled with the company ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks to buy and hold for 10 years. When the stock market experiences a sharp decline ...

Novo Nordisk NOVO.B0.70%increase; green up pointing triangle said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense ...

Novo Nordisk A/S (NVO) is a high-quality biopharma company that has been a growth play well before its recent obesity drug hit. Shares were hyped a while ago, but have now declined so much that ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its ...